Stay updated on Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Sign up to get notified when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.6%
    Check dated 2025-05-08T04:56:47.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.5%
    Check dated 2025-05-01T01:52:03.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-04-23T18:19:03.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new clinical study involving Solu-medrol and Dexamethasone for treating Acute Myeloid Leukemia and Myelodysplastic Syndrome, with Bristol-Myers Squibb as a collaborator. The previous study details regarding nivolumab have been removed, indicating a shift in focus for the research.
    Difference
    38%
    Check dated 2025-04-16T14:14:54.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.4%
    Check dated 2025-04-09T08:45:35.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.4%
    Check dated 2025-04-01T23:07:02.000Z thumbnail image

Stay in the know with updates to Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.